The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.
2.
Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.
3.
Outcomes in Resected Melanoma Influenced by Timing of Recurrence
4.
Survivors of childhood brain cancer are more likely to be held back in school
5.
10-year study shows tomosynthesis improves breast cancer detection
1.
Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients
2.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
3.
Unmasking the Subtle Symptoms of Colon Cancer
4.
Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders
5.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation